These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 2567647

  • 21. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB, Mahachai V.
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [Abstract] [Full Text] [Related]

  • 22. New H2-blockers: does more choice help?
    Drug Ther Bull; 1988 Aug 22; 26(17):65-6. PubMed ID: 3138097
    [No Abstract] [Full Text] [Related]

  • 23. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S, Sarem-Aslani A, Treiber G, Klotz U, Bode JC.
    Neth J Med; 1991 Feb 22; 38(1-2):18-23. PubMed ID: 1674363
    [Abstract] [Full Text] [Related]

  • 24. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N, Miwa T.
    Nihon Rinsho; 1988 Jan 22; 46(1):12-7. PubMed ID: 2897482
    [No Abstract] [Full Text] [Related]

  • 25. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK, Sung JJ.
    N Engl J Med; 1998 Jul 30; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract] [Full Text] [Related]

  • 26. Clinical importance of the new H2-antagonists.
    Walt RP.
    Methods Find Exp Clin Pharmacol; 1989 Jul 30; 11 Suppl 1():97-9. PubMed ID: 2566730
    [Abstract] [Full Text] [Related]

  • 27. Advances in the treatment of peptic ulcer disease.
    Camara DS.
    Compr Ther; 1987 Aug 30; 13(8):13-6. PubMed ID: 2887333
    [No Abstract] [Full Text] [Related]

  • 28. [Conservative treatment of uncomplicated peptic ulcer by various methods].
    Sülle C, Murasko V, Balalükin A, Maljarova L, Lapsina S, Zsuravlev A.
    Orv Hetil; 1985 Mar 31; 126(13):757-61. PubMed ID: 2859568
    [No Abstract] [Full Text] [Related]

  • 29. The medical management of peptic ulcer.
    Shearman DJ, Hetzel D.
    Annu Rev Med; 1979 Mar 31; 30():61-79. PubMed ID: 45409
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N, Sachdev A, Bhasin DK, Sankaranahyanan A, Khosla PP, Singh K, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul 31; 31(7):322-5. PubMed ID: 8103763
    [Abstract] [Full Text] [Related]

  • 32. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK, Evseev MA.
    Khirurgiia (Mosk); 2005 Jul 31; (8):52-7. PubMed ID: 16091681
    [Abstract] [Full Text] [Related]

  • 33. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H, Kawano S, Tsuji S, Oshita M, Nagano K, Ohmae A, Sawaoka H, Nagai Y, Kasahara A, Sugimoto T, Kamada T.
    Hepatogastroenterology; 1996 Jul 31; 43(7):169-73. PubMed ID: 8682457
    [Abstract] [Full Text] [Related]

  • 34. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar 31; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 35. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
    Walker S, Krishna DR, Klotz U, Bode JC.
    Gut; 1989 Aug 31; 30(8):1105-9. PubMed ID: 2570008
    [Abstract] [Full Text] [Related]

  • 36. New drugs for peptic ulcer.
    Br Med J; 1980 Jul 12; 281(6233):95-6. PubMed ID: 6107146
    [No Abstract] [Full Text] [Related]

  • 37. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W.
    Internist (Berl); 1996 Sep 12; 37(9):937-8. PubMed ID: 8964690
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T.
    J Int Med Res; 1989 Sep 12; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [Abstract] [Full Text] [Related]

  • 39. [Anti-ulcer agents. Clinico-experimental findings].
    Dammann HG, Walter TA, Müller P, Simon B.
    Med Welt; 1984 Feb 17; 35(7):233-6. PubMed ID: 6546597
    [No Abstract] [Full Text] [Related]

  • 40. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T, Hirata W, Higichi S.
    Int J Clin Pharmacol Res; 2002 Feb 17; 22(2):29-35. PubMed ID: 12503773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.